A detailed history of Oracle Alpha Inc. transactions in Immuneering Corp stock. As of the latest transaction made, Oracle Alpha Inc. holds 11,165 shares of IMRX stock, worth $22,330. This represents 0.06% of its overall portfolio holdings.

Number of Shares
11,165
Previous 11,794 5.33%
Holding current value
$22,330
Previous $86.7 Million 62.78%
% of portfolio
0.06%
Previous 0.11%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$1.91 - $7.32 $1,201 - $4,604
-629 Reduced 5.33%
11,165 $32.3 Million
Q4 2023

Feb 14, 2024

BUY
$4.84 - $8.44 $57,082 - $99,541
11,794 New
11,794 $86.7 Million

Others Institutions Holding IMRX

About Immuneering Corp


  • Ticker IMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,392,300
  • Market Cap $52.8M
  • Description
  • Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to tr...
More about IMRX
Track This Portfolio

Track Oracle Alpha Inc. Portfolio

Follow Oracle Alpha Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oracle Alpha Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oracle Alpha Inc. with notifications on news.